Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Benign prostatic hyperplasia. Shared care between urologists and general practitioners]

T Talseth1, H Hedlund

  • 1Kirurgisk avdeling A Rikshospitalet.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|January 30, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of full thickness focal cartilage lesions with a metallic resurfacing implant in a sheep animal model, 1 year evaluation.

Osteoarthritis and cartilage·2015
Same author

Primary evaluation of patients suspected of having interstitial cystitis (IC).

European urology·2004
Same author

Priapism of the glans and corpus spongiosum. Report of two cases with angiography.

Acta radiologica (Stockholm, Sweden : 1987)·2003
Same author

Clinical trial designs: is it possible to have a unified approach and common end points?

International journal of impotence research·2002
Same author

The pharmacology and clinical pharmacokinetics of apomorphine SL.

BJU international·2001
Same author

The clinical value of dynamic magnetic resonance imaging in normal and incontinent women--a preliminary study on micturition.

Scandinavian journal of urology and nephrology. Supplementum·2001

General practitioners can now manage mild to moderate benign prostatic hyperplasia (BPH) symptoms with new medications. Urologists remain essential for severe cases, ensuring collaborative patient care.

Area of Science:

  • Urology
  • Pharmacology
  • Internal Medicine

Context:

  • Historically, benign prostatic hyperplasia (BPH) management was exclusively the domain of urologists, involving surgical interventions for urethral obstruction.
  • Advancements in understanding lower urinary tract physiology and pharmacology have significantly evolved BPH treatment paradigms.

Purpose:

  • To explore the expanding role of general practitioners in managing benign prostatic hyperplasia (BPH).
  • To delineate the criteria for medical management and watchful waiting in BPH by general practitioners.
  • To emphasize the collaborative care model between general practitioners and urologists for BPH patients.

Summary:

  • New pharmacological agents offer effective treatment for mild to moderate benign prostatic hyperplasia (BPH) symptoms.

Related Experiment Videos

  • General practitioners can initiate medical treatment for BPH if urinalysis and creatinine levels are normal, and malignancy is not suspected.
  • Watchful waiting is a viable option for mild to moderate BPH without significant obstruction.

    • Impact:

    • Empowers general practitioners to manage a broader spectrum of benign prostatic hyperplasia (BPH) cases, improving patient access to care.
    • Facilitates a shared care model, optimizing resource utilization and patient outcomes in benign prostatic hyperplasia (BPH) management.
    • Reduces the burden on specialist urology services by enabling primary care management of less complex benign prostatic hyperplasia (BPH) cases.